• Return to Headlines

Akebia Therapeut Has Returned 57.5% Since SmarTrend Recommendation (AKBA)

By Shiri Gupta

SmarTrend identified an Uptrend for Akebia Therapeut (NASDAQ:AKBA) on November 25th, 2019 at $4.54. In approximately 2 months, Akebia Therapeut has returned 57.49% as of today's recent price of $7.15.

In the past 52 weeks, Akebia Therapeut share prices have been bracketed by a low of $2.99 and a high of $9.30 and are now at $7.15, 139% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has advanced 3.5%.

Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Akebia Therapeut shares.

Log in and add Akebia Therapeut (AKBA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights akebia therapeut

Ticker(s): AKBA